We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+12.58%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$24B
AUM Growth
+$1.56B
(+6.9%)
Cap. Flow
-$931M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
2,059
New
128
Increased
454
Reduced
915
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$36.7M |
| 2 |
VICI Properties
VICI
|
+$32.5M |
| 3 |
Elevance Health
ELV
|
+$27.3M |
| 4 |
Arch Capital
ACGL
|
+$24.7M |
| 5 |
Kite Realty
KRG
|
+$24.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$55.4M |
| 2 |
Apple
AAPL
|
+$48.9M |
| 3 |
Synopsys
SNPS
|
+$44.7M |
| 4 |
Netflix
NFLX
|
+$40.2M |
| 5 |
Markel Group
MKL
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 12.06% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Enanta Pharmaceuticals
ENTA
$372M
| $175K | ﹤0.01% |
18,700
+3,200
| +21% | +$29.8K |
|
1602
Liberty Latin America Class C
LILAK
$1.5B
| $175K | ﹤0.01% |
26,290
-69,630
| -73% | -$451K |
|
|
UCB
1603
United Community Banks
UCB
$4.22B
| $175K | ﹤0.01% |
6,000
+900
| +18% | +$23K |
|
1604
Worthington Steel
WS
$1.8B
| $174K | ﹤0.01% |
+6,200
| New | +$170K |
|
1605
Gold Fields
GFI
$29.2B
| $173K | ﹤0.01% |
12,000
| – | – |
|
1606
Dycom Industries
DY
$12.9B
| $172K | ﹤0.01% |
1,500
+500
| +50% | +$47.5K |
|
1607
Ocular Therapeutix
OCUL
$1.86B
| $170K | ﹤0.01% |
38,200
| – | – |
|
1608
Omega Flex
OFLX
$298M
| $169K | ﹤0.01% |
2,400
| – | – |
|
1609
Integer Holdings
ITGR
$3.35B
| $168K | ﹤0.01% |
1,700
+600
| +55% | +$51.6K |
|
1610
Kadant
KAI
$3.69B
| $168K | ﹤0.01% |
600
+400
| +200% | +$100K |
|
|
ADAM
1611
Adamas Trust
ADAM
$777M
| $167K | ﹤0.01% |
19,625
| – | – |
|
1612
Walker & Dunlop
WD
$1.65B
| $166K | ﹤0.01% |
1,500
+800
| +114% | +$65.7K |
|
1613
M/I Homes
MHO
$3.83B
| $165K | ﹤0.01% |
1,200
+900
| +300% | +$90K |
|
|
REVG
1614
DELISTED
REV Group
REVG
| $165K | ﹤0.01% |
9,100
| – | – |
|
1615
American Well
AMWL
$181M
| $164K | ﹤0.01% |
5,510
| – | – |
|
1616
Belden
BDC
$4B
| $162K | ﹤0.01% |
2,100
-3,700
| -64% | -$275K |
|
1617
NorthWestern Energy
NWE
$4.48B
| $162K | ﹤0.01% |
3,200
-800
| -20% | -$39.9K |
|
1618
Resideo Technologies
REZI
$5.23B
| $161K | ﹤0.01% |
8,600
-9,900
| -54% | -$162K |
|
|
KREF
1619
KKR Real Estate Finance Trust
KREF
$472M
| $160K | ﹤0.01% |
12,100
| – | – |
|
1620
ACI Worldwide
ACIW
$5.72B
| $159K | ﹤0.01% |
5,200
+3,500
| +206% | +$87.6K |
|
1621
Cogent Communications
CCOI
$594M
| $159K | ﹤0.01% |
2,100
+300
| +17% | +$20K |
|
1622
Methode Electronics
MEI
$543M
| $159K | ﹤0.01% |
7,000
| – | – |
|
1623
Glaukos
GKOS
$9.02B
| $158K | ﹤0.01% |
2,000
-1,500
| -43% | -$102K |
|
1624
Arcus Biosciences
RCUS
$3.57B
| $158K | ﹤0.01% |
8,300
+5,900
| +246% | +$94.3K |
|
|
SAGE
1625
DELISTED
Sage Therapeutics
SAGE
| $158K | ﹤0.01% |
7,300
| – | – |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2023 Portfolio in Review
As of Q4 2023, STRS Ohio held 2,059 positions worth $24B, up 6.9% from $22.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
STRS Ohio withdrew a net $931M in Q4 2023, closing 153 positions and reducing 915 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $55.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, STRS Ohio opened a new position in Synovus worth $16.4M.
- STRS Ohio's largest Q4 2023 buy was Synovus: 436,000 shares worth $16.4M.
- STRS Ohio added most to Broadcom in Q4 2023, an estimated $36.7M increase.
- STRS Ohio's biggest Q4 2023 reduction was Apple, cutting an estimated $48.9M.
- STRS Ohio fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $55.4M.
- STRS Ohio's ten largest holdings make up 25% of its $24B portfolio in Q4 2023.
- STRS Ohio opened 128 new positions and closed 153 in Q4 2023.
- STRS Ohio's portfolio value rose 6.9% quarter-over-quarter to $24B.
Based on STRS Ohio's 13F filing for Q4 2023, filed 30 Jan 2024.